Citation Impact
1 from Science/Nature 10 standout
Citing Papers
Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
2023 Standout
Advances in systemic therapies for triple negative breast cancer
2023 Standout
Works of Kurt Diebold being referenced
Abstract P2-08-10: Similarities between low hormone receptor positive and hormone receptor negative breast cancer: An analysis of 4366 patients from multicenter clinical trials
2019
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer—results from the GeparQuattro study (GBG 40)
2011
Author Peers
| Author | Cancer Research | Oncology | Hematology | PFM | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Kurt Diebold | 32 | 27 | 3 | 15 | 5 | 41 | |
| Niels Hackius | 4 | 307 | |||||
| Jane Stephens | 20 | 229 | |||||
| U Plengvanit | 18 | 51 | 2 | 20 | 27 | 336 | |
| Theresa M. Crytzer | 1 | 84 | 23 | 364 | |||
| Vassilios Profillidis | 21 | 213 |
All Works
Loading papers...